Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century

INTRODUCTION: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially in older patients. Here, we examine survival of patients with CML in Germany...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulte, Dianne, Barnes, Benjamin, Jansen, Lina, Eisemann, Nora, Emrich, Katharina, Gondos, Adam, Hentschel, Stefan, Holleczek, Bernd, Kraywinkel, Klaus, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848850/
https://www.ncbi.nlm.nih.gov/pubmed/24499592
http://dx.doi.org/10.1186/1756-8722-6-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848850/
https://www.ncbi.nlm.nih.gov/pubmed/24499592
http://dx.doi.org/10.1186/1756-8722-6-70

Ejemplares similares